New South Wales Bills Explanatory Notes

[Index] [Search] [Download] [Bill] [Help]


DRUG MISUSE AND TRAFFICKING AMENDMENT (MEDICALLY SUPERVISED INJECTING CENTRE) BILL 2010

Explanatory Notes

Explanatory note
This explanatory note relates to this Bill as introduced into Parliament.

Overview of Bill


The object of this Bill is to amend the Drug Misuse and Trafficking Act 1985 to
enable the medically supervised injecting centre in Kings Cross to operate on an
ongoing basis. At present, the centre is operating for a trial period that began on
1 May 2001 and is due to expire on 31 October 2011.

The Bill also repeals the Drug Summit Legislative Response Act 1999, which only
contains spent provisions relating to the Drug Offensive Council, Foundation and
Fund.

Outline of provisions


Clause 1 sets out the name (also called the short title) of the proposed Act.

Clause 2 provides for the commencement of the proposed Act on the date of assent
to the proposed Act.

Clause 3 repeals the Drug Summit Legislative Response Act 1999.


Explanatory note page 2

Drug Misuse and Trafficking Amendment (Medically Supervised Injecting Centre) Bill 2010
Explanatory note
Schedule 1 Amendment of Drug Misuse and
Trafficking Act 1985 No 226
Schedule 1 [1]-[3], [5], [6] and [8] remove references in various provisions to the
trial period due to end on 31 October 2011, which has the effect of enabling the
licensed injecting centre to operate on an ongoing basis.

Schedule 1 [4] sets out the objects of Part 2A (Medically supervised injecting
centres) of the Drug Misuse and Trafficking Act 1985 and requires the Minister to
review the operation of that Part after 5 years from the commencement of the
proposed Act. A report of the outcome of the review is to be tabled in Parliament.

Schedule 1 [7] authorises the responsible authorities (the Commissioner of Police
and the Director-General of the Department of Health) to revoke a licence in certain
circumstances.

Schedule 1 [9] inserts a savings provision to ensure that the existing licence
continues without the need to be re-issued at the end of the trial period.

Note: If this Bill is not modified, these Explanatory Notes would reflect the Bill as passed in the House. If the Bill has been amended by Committee, these Explanatory Notes may not necessarily reflect the Bill as passed.

 


[Index] [Search] [Download] [Bill] [Help]